MissionIR Articles
-
MissionIRNewsBreaks – Net Element Inc. (NASDAQ: NETE) Looks to Compelling Opportunity Through Pending Reverse-Merger
Net Element (NASDAQ: NETE) previously entered a definitive agreement to merge with Mullen Technologies, a Southern California-based electric vehicle (“EV”) company, in a move intended to maximize shareholder value. The pending reverse-merger will allow privately-held…
-
MissionIRNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Featured in Simply Wall St Article
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company focused on the development of drug products for patients with high unmet medical need conditions or no alternative treatment options, was featured in a Simply Wall St…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Begins Manufacturing of Lead Drug Candidate in Europe
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, today announced that its European manufacturer, BSP Pharmaceuticals S.p.A.…
-
MissionIRNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Provides Update on Portfolio Expansion in the US
Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today provided an update on the progress of three of its portfolio companies in U.S. markets. The updates come only weeks before…
-
MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Offers Real-Time Access to Pharmaceuticals to Increase Competition, Reduce Costs
Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, assists pharmacies in cutting costs in an era where the pricing of medication poses a major challenge that significantly inflates health-care spending. Trxade’s pharmaceutical…
-
MissionIRNewsBreaks – VistaGen Therapeutics (NASDAQ: VTGN) Featured in Research Report
VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, was featured in a recent research report by Aegis Capital Corp. The report…
-
MissionIRNewsBreaks – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Announces Board Appointment of Seasoned Retail Veteran
The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, today announced the appointment of retail industry veteran Frank Lazaran to its board of…
-
MissionIRNewsBreaks – Why VistaGen Therapeutics (NASDAQ: VTGN) Is ‘One to Watch’
VistaGen Therapeutics (NASDAQ: VTGN) is a biopharmaceutical company committed to developing and commercializing a new generation of medications that go beyond the standard of care for anxiety, depression and other central nervous system (“CNS”) disorders.…
-
SRAX Inc. (NASDAQ: SRAX) Announces Acquisition of Micro-Cap Specialist Data Company, LD Micro
SRAX has announced acquisition of LD Micro, a leading data company serving small and micro-cap listed company space SRAX will pay gross consideration of 1.6 million new SRAX shares along with four $1 million installments…
-
MissionIRNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Further Strengthens Market Presence in Education Sector
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a leading producer, developer and operator of augmented reality (“AR”) interactive entertainment games, toys and educational materials in China, today announced a strategic collaboration. According to the update,…
-
MissionIRNewsBreaks – Genprex Inc. (NASDAQ: GNPX) CEO Scheduled to Present at LD Micro Event
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, is slated to present at an upcoming LD Micro virtual event. GNPX’s Zoom presentation is scheduled for…
-
MissionIRNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Closing of Public Offering
Processa Pharmaceuticals (NASDAQ: PCSA) has closed its previously announced underwritten public offering of 4,800,000 shares of common stock, which were offered to the public for $4 per share. The clinical-stage biopharmaceutical company, which focuses on…
-
MissionIRNewsBreaks – 180 Life Sciences Corp. Continues to Broaden Global IP Portfolio, Expand Internal Pipeline
KBL Merger Corp. (NASDAQ: KBLM) (KBL Merger Corp. Rights NASDAQ: KBLMR) (KBL Merger Corp. Warrant NASDAQ: KBLMW), a Special Purpose Acquisition Corporation (SPAC) that previously entered a definitive agreement to acquire 180 Life Sciences, a…
-
Net Element Inc. (NASDAQ: NETE), Mullen Technologies Announce Facility Build-Out, Pre-Sales of Fully Electric EV
Mullen Technologies begins built-out of pilot facility, accepting orders for MX-05 SUV. Facility slated for April 2021 completion; first MX-05 SUVs rolling off production line by Q2 2022. In August, Net Element, Mullen Technologies announced…
-
MissionIRNewsBreaks – The Alkaline Water Company Inc.’s (CSE: WTER) (NASDAQ: WTER) A88 Infused(TM) Grabbing Shelf Space in Trend Expected to Accelerate
The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, today announced that its A88 Infused(TM) brand is gaining ground in the fast-growing flavored…
-
MissionIRNewsBreaks – Predictive Oncology (NASDAQ: POAI) Shareholder Letter Provides Company Update, Status of Subsidiaries
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has released a shareholder letter providing a review of where POAI “stands as of today.” The…
-
Processa Pharmaceuticals Inc. (NASDAQ: PCSA) is “One to Watch”
Processa Pharmaceuticals aims to develop products where existing clinical evidence of efficacy already exists in the targeted unmet medical need condition with the drug itself or a drug with very similar pharmacology The Processa process…
-
MissionIRNewsBreaks – Pressure BioSciences (PBIO) Locks In Final System Design, Begins Production of Alpha Unit
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, and other industries, has reached what it calls as…
-
MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Announces ‘Clean Slate’ from Debt Coupled with Strong Working Capital
Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading uranium producer in the United States, today announced that the company became debt-free following the retirement of its remaining C$10,430,000 of floating-rate convertible unsecured subordinated debentures…
-
MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Secures DOE Grant for Production of Rare Earth Elements
Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading producer of uranium in the United States, along with a team from Penn State University recently announced the award of a contract from the U.S. Department…
Search Articles
Latest Articles
- Nutriband Inc. (NASDAQ: NTRB) CEO Showcases AVERSA(TM) Abuse Deterrent Transdermal Technology at Emerging Growth Conference
- D-Wave Quantum Inc. (NYSE: QBTS) Releases New Tools to Advance Quantum AI Innovation and Exploration
- MissionIRNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics Closes Acquisition of Dura Medical
- MissionIRNewsBreaks – GlobalTech Corp. (OTC: GLTK) Closes $1.4 Million Convertible Note Private Placement
- Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Seizes Opportunities amid Rising Global Platinum Jewelry Demand